International Immunology, Vol. 12, No. 4, 467-477,
April 2000
© 2000 Japanese Society for Immunology
The role of antigen-independent persistence of memory cytotoxic T lymphocytes
Institute for Advanced Study, Olden Lane, Princeton, NJ 08540, USA
1 Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK
Correspondence to: D. Wordarz
We use mathematical models to analyze the role of a memory cytotoxic T lymphocyte (CTL) response in viral infections. The model predicts that antigen-independent persistence of an elevated number of precursor CTL (CTLp) does not protect the host from clinical symptoms upon re-infection. Instead, we find that antigen-independent long-term persistence of CTLp is required to clear virus infections. This mechanism also applies to infection in hosts that have never experienced the pathogen before. Requirement of antigen for the long-term maintenance of CTLp results in failure to clear the infection, even in hosts characterized by a high CTL responsiveness. We compare the CTL model to a B cell model. In keeping with experimentally established findings, B cells are efficient in protecting against re-infection, but are unlikely to clear viral infections unless the virus is cytopathic. We conclude that the role of `memory CTLp' is different from the role of memory B cells in viral infections: antigen-independent long-term persistence of CTLp is a pre-requisite to ensure clearance of infection.
Keywords: B cell memory, cytotoxic T lymphocyte memory, mathematical models, precursor life-span, protection, virus elimination
Transmitting editor: A. McMichael
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. V. Ganusov Discriminating between Different Pathways of Memory CD8+ T Cell Differentiation J. Immunol., October 15, 2007; 179(8): 5006 - 5013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Holst, C. Bartholdy, A. Stryhn, A. R. Thomsen, and J. P. Christensen Rapid and sustained CD4+ T-cell-independent immunity from adenovirus-encoded vaccine antigens J. Gen. Virol., June 1, 2007; 88(6): 1708 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Wahl, B. Bittner, and M. A. Nowak Immunological transitions in response to antigenic mutation during viral infection Int. Immunol., October 1, 2000; 12(10): 1371 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wodarz and M. A. Nowak HIV therapy: Managing resistance PNAS, July 18, 2000; 97(15): 8193 - 8195. [Full Text] [PDF]
|
|
|
|
|
|
C. Fraser, N. M. Ferguson, and R. M. Anderson Quantification of intrinsic residual viral replication in treated HIV-infected patients PNAS, December 18, 2001; 98(26): 15167 - 15172. [Abstract] [Full Text] [PDF]
|
|